Axa’s Confluent CFLT Stock Holding History

Axa’s Portfolio CFLT Stock Details CFLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-393,028	Closed	-$9.8M	–	259
2025 Q2	$9.8M	Buy	393,028 +88,565	+29%	+$2M	0.03%	403
2025 Q1	$7.14M	Buy	+304,463	New	+$8.82M	0.02%	459

Other funds holding CFLT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

ACM

Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return

OPFM

Optimus Prime Fund Management Grand Cayman, Cayman Islands $1.04B AUM 9.64% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa's CFLT Position: Q3 2025 in Review

Axa sold out of Confluent (CFLT) in Q3 2025, closing a stake of 393,028 shares — an estimated $9.8M sold.

Axa first reported a position in CFLT in Q1 2025 and held it in 2 quarters. The position peaked at $9.8M in Q2 2025. 385 funds tracked by Wall St. Rank hold CFLT as of Q3 2025.

Axa reported no remaining Confluent position as of Q3 2025 after selling out during the quarter.
Axa sold 393,028 Confluent shares in Q3 2025, an estimated $9.8M.
Axa first reported a position in Confluent in Q1 2025 and held it in 2 quarters.
Axa's Confluent position peaked at $9.8M in Q2 2025.
385 funds tracked by Wall St. Rank held Confluent as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.